Raskin P, Klaff L, Bergenstal R, Halle JP, Donley D, Mecca T: A 16-week compari- son of the novel insulin analog insulin glargine (HOE 901) and NPH human in- sulin used with insulin lispro in patients with type 1 diabetes. Diabetes Care 23: 1666 -1671, 200...
Currently, we have six core insulin products, including five insulin analog varieties: long-acting glargine injection (Basalin®), fast-acting lispro injection (Prandilin™), fast-acting aspart injection (Rapilin®), mixed protamine zinc lispro injection (25R) (Prandilin™25), aspart 30...
Carstensen B (2012) Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Diabetologia doi:10.1007/s00125-011-2436-6 ...
Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T: Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000, 23:644-649....
These guidelines are not intended to interfere with clinical judgment. Rather, they are intended to assist practitioners in providing consistent, high quality cost effective care.Deborah KhachikianPharm.D
Treatment with human analog ( GlyA21 , ArgB31 , ArgB32 ) insulin glargine ( HOE901 ) resolves a generalized allergy to human insulin in type 1 diabetes. Hiroaki M,Masao N,Kazuhiro F. Diabetes Care . 2001Hiroaki M, Masao N, Kazuhiro F. Treatment with human analog (GlyA21, ArgB31, ...
Quality of life of patients with type 1 diabetes mellitus using insulin analog glargine compared with NPH insulin: a systematic review and policy implications. Patient. 2018;11:377-89.Almeida PHRF, Silva TBC, de Assis Acurcio F, Guerra Junior AA, Araujo VE, Diniz LM, et al. Quality of...
Insulin GlargineInsulin AnalogInsulin AspartNo Abstract available for this article.doi:10.1007/s00508-006-0707-xDaniela ?echurováSilvie LacigováZdeněk JankovecIva HaladováMichal ?ourekMichal Kr?maZdeněk Ru?avyJi?í TurekWien Klin WochenschrWiener klinische Wochenschrift...
-IMJW CMB mg doxycycline scapularis and of Subcutaneous Pharmacokinetics Pharmacodynamics of Human Insulin Injection Long-Acting Analog Glargine, NPH Insulin, and Ultralente Human Insulin and Continuous Subcutaneous Infusion of Insulin Lispro Porcellati et Diabetes. Lepore M, Pampanelli S...
Real world outcomes of initiating glargine-based insulin treatment vs. analog premix insulin among patients with type 2 diabetes failing oral antidiabetes drugsO., BaserM., TangiralaW., WeiL., Xie